Difficult times for Alzheimer's treatments.
O'Neill
Michael F
MF
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control; D023582:Alzheimer Vaccines / Q000276:immunology / Q000627:therapeutic use; D016229:Amyloid beta-Peptides / Q000276:immunology; D014150:Antipsychotic Agents / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000191:economics / Q000627:therapeutic use; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D014810:Vitamin E / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use
D023582:Alzheimer Vaccines; D016229:Amyloid beta-Peptides; D014150:Antipsychotic Agents; D002800:Cholinesterase Inhibitors; D014815:Vitamins; D014810:Vitamin E